Supporting this hypothesis, recent work in an animal model of cancer demonstrated that neutralizing GDF-15 improved muscle function and physical performance, suggesting GDF-15 is a potential therapeutic target in myopathies [20]. The gene discussed is GDF15; the disease is cancer.